Ariyoshi Y - Search Results

1

A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer.

Fukuoka M, Niitani H, Suzuki A, Motomiya M, Hasegawa K, Nishiwaki Y, Kuriyama T, Ariyoshi Y, Negoro S, Masuda N, et al. Fukuoka M, et al. Among authors: ariyoshi y. J Clin Oncol. 1992 Jan;10(1):16-20. doi: 10.1200/JCO.1992.10.1.16. J Clin Oncol. 1992. PMID: 1309380 Clinical Trial.

2

[Early phase II study of BMS-181339 (paclitaxel) in patients with non-small cell lung cancer. BMS-181339 Non-Small Cell Lung Cancer Study Group].

Yoneda S, Nishiwaki Y, Niitani H, Kurita Y, Ariyoshi Y, Ikegami H, Furuse K, Fukuoka M, Kimura I, Hara N, Saijo N. Yoneda S, et al. Among authors: ariyoshi y. Gan To Kagaku Ryoho. 1996 May;23(6):695-701. Gan To Kagaku Ryoho. 1996. PMID: 8645020 Clinical Trial. Japanese.

3

Phase II study of irinotecan combined with cisplatin in patients with previously untreated small-cell lung cancer. West Japan Lung Cancer Group.

Kudoh S, Fujiwara Y, Takada Y, Yamamoto H, Kinoshita A, Ariyoshi Y, Furuse K, Fukuoka M. Kudoh S, et al. Among authors: ariyoshi y. J Clin Oncol. 1998 Mar;16(3):1068-74. doi: 10.1200/JCO.1998.16.3.1068. J Clin Oncol. 1998. PMID: 9508192 Clinical Trial.

4

Phase III study of intensive weekly chemotherapy with recombinant human granulocyte colony-stimulating factor versus standard chemotherapy in extensive-disease small-cell lung cancer. The Japan Clinical Oncology Group.

Furuse K, Fukuoka M, Nishiwaki Y, Kurita Y, Watanabe K, Noda K, Ariyoshi Y, Tamura T, Saijo N. Furuse K, et al. Among authors: ariyoshi y. J Clin Oncol. 1998 Jun;16(6):2126-32. doi: 10.1200/JCO.1998.16.6.2126. J Clin Oncol. 1998. PMID: 9626212 Clinical Trial.

5

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.

Furuse K, Fukuoka M, Kawahara M, Nishikawa H, Takada Y, Kudoh S, Katagami N, Ariyoshi Y. Furuse K, et al. Among authors: ariyoshi y. J Clin Oncol. 1999 Sep;17(9):2692-9. doi: 10.1200/JCO.1999.17.9.2692. J Clin Oncol. 1999. PMID: 10561343 Clinical Trial.

6

Phase II study of concurrent chemotherapy and radiotherapy for unresectable stage III non-small-cell lung cancer: long-term follow-up results. Japan Clinical Oncology Group Protocol 8902.

Kubota K, Tamura T, Fukuoka M, Furuse K, Ikegami H, Ariyoshi Y, Kurita Y, Saijo N. Kubota K, et al. Among authors: ariyoshi y. Ann Oncol. 2000 Apr;11(4):445-50. doi: 10.1023/a:1008328207137. Ann Oncol. 2000. PMID: 10847464 Free article. Clinical Trial.

7

Phase I-II study of amrubicin and cisplatin in previously untreated patients with extensive-stage small-cell lung cancer.

Ohe Y, Negoro S, Matsui K, Nakagawa K, Sugiura T, Takada Y, Nishiwaki Y, Yokota S, Kawahara M, Saijo N, Fukuoka M, Ariyoshi Y. Ohe Y, et al. Among authors: ariyoshi y. Ann Oncol. 2005 Mar;16(3):430-6. doi: 10.1093/annonc/mdi081. Epub 2005 Jan 14. Ann Oncol. 2005. PMID: 15653702 Free article. Clinical Trial.

8

Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan.

Ohe Y, Ohashi Y, Kubota K, Tamura T, Nakagawa K, Negoro S, Nishiwaki Y, Saijo N, Ariyoshi Y, Fukuoka M. Ohe Y, et al. Among authors: ariyoshi y. Ann Oncol. 2007 Feb;18(2):317-23. doi: 10.1093/annonc/mdl377. Epub 2006 Nov 1. Ann Oncol. 2007. PMID: 17079694 Free article. Clinical Trial.

9

The use of granulocyte colony-stimulating factor to shorten the interval between cycles of mitomycin C, vindesine, and cisplatin chemotherapy in non-small-cell lung cancer.

Takada M, Fukuoka M, Ariyoshi Y, Furuse K, Niitani H, Ota K, Motomiya M, Hasegawa K, Tominaga K, Kuriyama T, et al. Takada M, et al. Among authors: ariyoshi y. Cancer Chemother Pharmacol. 1992;31(3):182-6. doi: 10.1007/BF00685545. Cancer Chemother Pharmacol. 1992. PMID: 1281446 Clinical Trial.

10

Phase I/II study of amrubicin, a novel 9-aminoanthracycline, in patients with advanced non-small-cell lung cancer.

Sugiura T, Ariyoshi Y, Negoro S, Nakamura S, Ikegami H, Takada M, Yana T, Fukuoka M. Sugiura T, et al. Among authors: ariyoshi y. Invest New Drugs. 2005 Aug;23(4):331-7. doi: 10.1007/s10637-005-1441-3. Invest New Drugs. 2005. PMID: 16012792 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

300 results

Search Page

Filters